1. Home
  2. CELU vs CULP Comparison

CELU vs CULP Comparison

Compare CELU & CULP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • CULP
  • Stock Information
  • Founded
  • CELU 2016
  • CULP 1972
  • Country
  • CELU United States
  • CULP United States
  • Employees
  • CELU N/A
  • CULP N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • CULP Textiles
  • Sector
  • CELU Health Care
  • CULP Consumer Discretionary
  • Exchange
  • CELU Nasdaq
  • CULP Nasdaq
  • Market Cap
  • CELU 56.9M
  • CULP 52.7M
  • IPO Year
  • CELU N/A
  • CULP N/A
  • Fundamental
  • Price
  • CELU $1.96
  • CULP $4.01
  • Analyst Decision
  • CELU Strong Buy
  • CULP
  • Analyst Count
  • CELU 1
  • CULP 0
  • Target Price
  • CELU $6.00
  • CULP N/A
  • AVG Volume (30 Days)
  • CELU 69.1K
  • CULP 24.2K
  • Earning Date
  • CELU 11-14-2025
  • CULP 12-10-2025
  • Dividend Yield
  • CELU N/A
  • CULP N/A
  • EPS Growth
  • CELU N/A
  • CULP N/A
  • EPS
  • CELU N/A
  • CULP N/A
  • Revenue
  • CELU $40,578,000.00
  • CULP $207,391,000.00
  • Revenue This Year
  • CELU N/A
  • CULP $1.93
  • Revenue Next Year
  • CELU $76.00
  • CULP $2.77
  • P/E Ratio
  • CELU N/A
  • CULP N/A
  • Revenue Growth
  • CELU N/A
  • CULP N/A
  • 52 Week Low
  • CELU $1.00
  • CULP $3.42
  • 52 Week High
  • CELU $4.35
  • CULP $5.94
  • Technical
  • Relative Strength Index (RSI)
  • CELU 57.50
  • CULP 49.15
  • Support Level
  • CELU $1.62
  • CULP $3.78
  • Resistance Level
  • CELU $2.29
  • CULP $3.89
  • Average True Range (ATR)
  • CELU 0.15
  • CULP 0.13
  • MACD
  • CELU 0.06
  • CULP 0.03
  • Stochastic Oscillator
  • CELU 63.29
  • CULP 55.56

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About CULP Culp Inc.

Culp Inc manufactures, markets mattress fabrics for bedding and upholstery fabrics for residential, commercial, and hospitality furnishings. The company has two operating segments: Mattress fabrics, which generate maximum revenue, and Upholstery fabrics. The mattress fabrics segment manufactures, sources, and sells fabrics and mattress covers to bedding manufacturers. The upholstery fabrics segment develops, sources, manufactures, and sells fabrics to residential, commercial, and hospitality furniture manufacturers. Geographically, it derives key revenue from the United States of America.

Share on Social Networks: